216
Views
1
CrossRef citations to date
0
Altmetric
Articles

Language proficiency and biologics access: a population study of psoriasis patients in the United States

ORCID Icon, , , , & ORCID Icon
Pages 1413-1417 | Received 28 Jul 2020, Accepted 28 Aug 2020, Published online: 14 Sep 2020

References

  • Takeshita J, Grewal S, Langan SM, et al. Psoriasis and comorbid diseases: epidemiology. J Am Acad Dermatol. 2017;76(3):377–390.
  • Singh S, Taylor C, Kornmehl H, et al. Psoriasis and suicidality: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(3):425–440.
  • Fleming P, Bai JW, Pratt M, et al. The prevalence of anxiety in patients with psoriasis: a systematic review of observational studies and clinical trials. J Eur Acad Dermatol Venereol. 2017;31(5):798–807.
  • Armstrong AW, Schupp C, Wu J, et al. Quality of life and work productivity impairment among psoriasis patients: findings from the National Psoriasis Foundation survey data 2003-2011. PLoS One. 2012;7(12):e52935.
  • Yeung H, Takeshita J, Mehta NN, et al. Psoriasis severity and the prevalence of major medical comorbidity: a population-based study. JAMA Dermatol. 2013;149(10):1173–1179.
  • Semenov YR, Herbosa CM, Rogers AT, et al. Psoriasis and mortality in the US: data from the National Health and Nutrition Examination Survey. J Am Acad Dermatol. 2019. DOI:10.1016/j.jaad.2019.08.011
  • Dhana A, Yen H, Yen H, et al. All-cause and cause-specific mortality in psoriasis: a systematic review and meta-analysis. J Am Acad Dermatol. 2019;80(5):1332–1343.
  • Salame N, Ehsani-Chimeh N, Armstrong AW. Comparison of physical and mental functioning among moderate-to-severe psoriasis patients on biologic versus oral therapy. Arch Dermatol Res. 2019;311(6):453–460.
  • Salame N, Ehsani-Chimeh N, Armstrong AW. Comparison of mental health outcomes among adults with psoriasis on biologic versus oral therapies: a population-based study. J Dermatolog Treat. 2019;30(2):135–140.
  • Frieder J, Kivelevitch D, Fiore CT, et al. The impact of biologic agents on health-related quality of life outcomes in patients with psoriasis. Expert Rev Clin Immunol. 2018;14(1):1–19.
  • Takeshita J, Gelfand JM, Li P, et al. Psoriasis in the US Medicare Population: prevalence, treatment, and factors associated with biologic use. J Invest Dermatol. 2015;135(12):2955–2963.
  • Armstrong AW, Koning JW, Rowse S, et al. Under-treatment of patients with moderate to severe psoriasis in the United States: analysis of medication usage with health plan data. Dermatol Ther. 2017;7(1):97–109.
  • Kamangar F, Isip L, Bhutani T, et al. How psoriasis patients perceive, obtain, and use biologic agents: survey from an academic medical center. J Dermatolog Treat. 2013;24(1):13–24.
  • Geale K, Henriksson M, Schmitt-Egenolf M. Evaluating equality in psoriasis healthcare: a cohort study of the impact of age on prescription of biologics. Br J Dermatol. 2016;174(3):579–587.
  • Takeshita J, Eriksen WT, Raziano VT, et al. Racial differences in perceptions of psoriasis therapies: implications for racial disparities in psoriasis treatment. J Invest Dermatol. 2019;139(8):1672–1679.
  • Ashbaugh AG, Ekelem C, Landaverde Y, et al. Psoriatic disease in the US Latino population: a comprehensive review. Am J Clin Dermatol. 2020;21(2):265–274.
  • Kerr GS, Qaiyumi S, Richards J, et al. Psoriasis and psoriatic arthritis in African-American patients – the need to measure disease burden. Clin Rheumatol. 2015;34(10):1753–1759.
  • U.S. Census Bureau. American Community Survey 1-year estimates [Internet]. Washington (DC): U.S. Census Bureau; 2017 [cited 2020 Jan 20]. Available from: https://factfinder.census.gov/faces/tableservices/jsf/pages/productview.xhtml?src=bkmk
  • Berdahl TA, Kirby JB. Patient–provider communication disparities by limited English proficiency (LEP): trends from the US medical expenditure panel survey, 2006–2015. J Gen Intern Med. 2019;34(8):1434–1440.
  • Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
  • Perez GK, Mutchler J, Yang MS, et al. Promoting quality care in patients with cancer with limited English proficiency: perspectives of medical interpreters. Psychooncology. 2016;25(10):1241–1245.
  • Davis RE, Peterson KE, Rothschild SK, et al. Pushing the envelope for cultural appropriateness: does evidence support cultural tailoring in type 2 diabetes interventions for Mexican American adults? Diabetes Educ. 2011;37(2):227–238.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.